Connecting you to content on EBSCOhost

Works by Smith, Lon

Results: 5

1

Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 911, doi. 10.1007/s00280-007-0672-8

By:

Rodon, Jordi;
Garrison, Mitchell;
Hammond, Lisa A.;
de Bono, Johann;
Smith, Lon;
Forero, Leonardo;
Hao, Desirée;
Takimoto, Chris;
Lambert, John M.;
Pandite, Lini;
Howard, Maria;
Hongsheng Xie;
Tolcher, Anthony W.

Publication type:

Article

2

A Phase I Dose-Escalation and Dose-Expansion Study of FCN-437c, a Novel CDK4/6 Inhibitor, in Patients with Advanced Solid Tumors.

Published in:

Cancers, 2022, v. 14, n. 20, p. 4996, doi. 10.3390/cancers14204996

By:

Patnaik, Amita;
Hamilton, Erika;
Xing, Yan;
Rasco, Drew W.;
Smith, Lon;
Lee, Ya-Li;
Fang, Steven;
Wei, Jiao;
Hui, Ai-Min

Publication type:

Article

3

Treatment strategies for plasma cell myeloma.

Published in:

1985

By:

Smith, Lon;
Alexanian, Raymond;
Smith, L;
Alexanian, R

Publication type:

journal article

4

A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.

Published in:

Oncologist, 2018, v. 23, n. 6, p. 658, doi. 10.1634/theoncologist.2017-0325

By:

Tolcher, Anthony;
Flaherty, Keith;
Shapiro, Geoffrey I.;
Berlin, Jordan;
Witzig, Thomas;
Habermann, Thomas;
Bullock, Andrea;
Rock, Edwin;
Elekes, Agnes;
Lin, Chester;
Kostic, Dusan;
Ohi, Naoto;
Rasco, Drew;
Papadopoulos, Kyriakos P.;
Patnaik, Amita;
Smith, Lon;
Cote, Gregory M.

Publication type:

Article

5

Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer.

Published in:

Breast Cancer Research & Treatment, 2014, v. 148, n. 3, p. 571, doi. 10.1007/s10549-014-3191-4

By:

Rangel, Leticia;
Taraba, Jodi;
Frei, Christopher;
Smith, Lon;
Rodriguez, Gladys;
Kuhn, John

Publication type:

Article